United Kingdom · Question · Written question
UIN 7923
Sickle Cell Diseases
Original
Introduced
26 May 2021
Last action
10 June 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 June 2021
Summary
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the (a) availability of and (b) access to innovative treatments for sickle cell disease in the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
26 May 2021
Written question
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the (a) availability of and (b) access to innovative treatments for sickle cell disease in the NHS.
Source: Commons
10 June 2021
Answer
The National Institute for Health and Care Excellence (NICE) is currently developing guidance on the use of crizanlizumab for preventing sickle cell crises in sickle cell disease and expects to publish its final recommendation in September 2021. In additi...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-05-26/7923
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1328310
- uk · wq-1328310 · source updated 10 June 2021